The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Jun. 17, 2025

Filed:

Feb. 29, 2024
Applicant:

Axcess Global Sciences, Llc, Salt Lake City, UT (US);

Inventor:

Gary Millet, Salt Lake City, UT (US);

Assignee:

AXCESS GLOBAL SCIENCES, LLC, Washington, UT (US);

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 31/22 (2006.01); A61K 9/00 (2006.01); A61K 31/047 (2006.01); A61K 31/19 (2006.01);
U.S. Cl.
CPC ...
A61K 31/22 (2013.01); A61K 9/0053 (2013.01); A61K 31/047 (2013.01); A61K 31/19 (2013.01); A23V 2200/3322 (2013.01);
Abstract

Compositions for inducing and maintaining a state of flow in a subject include optically pure S-beta-hydroxybutyrate or non-racemic mixtures enriched with the S-enantiomer. The S-beta-hydroxybutyrate enantiomer modulates the effect of ketone bodies in the subject and controls the rate at which ketosis is achieved. Beta-hydroxybutyric acid is more rapidly absorbed and utilized by the body than salts or esters, enhances taste, and reduces the need to include citric acid or other edible acids. Beta-hydroxybutyrate salts are more slowly absorbed and utilized by the body and can provide one or more electrolytes. Compositions for controlling ketone body level in a subject may contain a dietetically or pharmaceutically acceptable carrier and optically pure S-beta-hydroxybutyrate or non-racemic mixture enriched with S-beta-hydroxybutyrate, wherein the compositions contain from about 50.5% to 100% by enantiomeric equivalents of S-beta-hydroxybutyrate and from about 49.5% to 0% by enantiomeric equivalents of R-beta-hydroxybutyrate.


Find Patent Forward Citations

Loading…